Bristol Myers Squibb (CELG-RI) Cash from Operations Growth (5y) (2014 - 2026)

Bristol Myers Squibb (CELG-RI) Cash from Operations Growth (5y) (2014 - 2026) Analysis & Trends

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn
10 Bristol Myers Squibb - - 8.07 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 -22.00%
Dec 31, 2025 -10.06%
Sep 30, 2025 22.72%
Jun 30, 2025 -2.71%
Mar 31, 2025 -13.07%
Dec 31, 2024 15.27%
Sep 30, 2024 16.95%
Jun 30, 2024 2.23%
Mar 31, 2024 15.31%
Dec 31, 2023 3.65%
Sep 30, 2023 30.01%
Jun 30, 2023 12.29%
Mar 31, 2023 20.38%
Dec 31, 2022 24.24%
Sep 30, 2022 16.57%
Jun 30, 2022 7.38%
Mar 31, 2022 34.66%
Dec 31, 2021 22.97%
Sep 30, 2021 30.26%
Jun 30, 2021 47.45%